We therefore investigated to determine whether the protective effects of DEL-1 on ANGII-induced cardiovascular remodeling and development of hypertension are associated with DEL-1–mediated inhibition of IL-17–dependent inflammation. Here, EDIL3 is linked to hypertensive disorder.